Question

STUDY QUESTION: Does use of diet drug fen-phen (fenfluramine-phentermine) cause valvular heart disease? HINT: Valvular heart...

STUDY QUESTION: Does use of diet drug fen-phen (fenfluramine-phentermine) cause valvular heart disease?

HINT: Valvular heart disease is most objectively identified by echocardiography. A fairly high percentage of persons with valvular heart disease don’t have a detectable heart murmur and thus, would not be identified by physical examination alone. For this study, valvular heart disease will include mitral and aortic regurgitation. These are graded as absent, trace, mild, moderate, and severe. The Food and Drug Administration (FDA) criterion for significant mitral valve regurgitation is moderate or higher; for aortic regurgitation the criterion is mild or higher.

DESIGN 2: CROSS-SECTIONAL STUDY

Briefly describe the layout of a cross-sectional study designed to address the study question. In formulating your description, consider the following points:

1. How will the study participants be selected?

Answer:

2. How will information on the exposure and the outcome be collected (ascertained)?

Answer:

HINT: Since these drugs have been taken off the market, it would not be possible to do a cross-sectional study now. In designing your study, assume that the drugs are still being prescribed.

0 0
Add a comment Improve this question Transcribed image text
Answer #1

Layout of the Study:

OBJECTIVE:To assess whether the diet drug fen-phen (fenfluramine-phentermine) causes valvular heart disease in a vulnerable population.

DESIGN:Cross-sectional study.

SETTING: Tertiary teaching hospital

A-1. Selection of study participants :

100 patients with previous exposure to fen-phen who are diagnosed with atleast mild mitral regurgitation or aortic regurgitation after exposure to fenfluramines should be considered and subjected to echocardiography.

A-2. A validated pre-tested questionnaire should be used to collect details of exposure and oucome.

Exposure in this case is..any history of consumption of fen-phen.(these are the vulnerable population)

Outcome is ...Assessment of severity of valvular regurgitation and presence or absence of valve leaflet restriction by subjecting the individuals to serial electrocardiogram.

  

Add a comment
Know the answer?
Add Answer to:
STUDY QUESTION: Does use of diet drug fen-phen (fenfluramine-phentermine) cause valvular heart disease? HINT: Valvular heart...
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for? Ask your own homework help question. Our experts will answer your question WITHIN MINUTES for Free.
Similar Homework Help Questions
  • STUDY QUESTION: Does use of diet drug fen-phen (fenfluramine-phentermine) cause valvular heart disease? HINT: Valvular heart...

    STUDY QUESTION: Does use of diet drug fen-phen (fenfluramine-phentermine) cause valvular heart disease? HINT: Valvular heart disease is most objectively identified by echocardiography. A fairly high percentage of persons with valvular heart disease don’t have a detectable heart murmur and thus, would not be identified by physical examination alone. For this study, valvular heart disease will include mitral and aortic regurgitation. These are graded as absent, trace, mild, moderate, and severe. The Food and Drug Administration (FDA) criterion for significant...

  • STUDY QUESTION: Does use of diet drug fen-phen (fenfluramine-phentermine) cause valvular heart disease? HINT: Valvular heart...

    STUDY QUESTION: Does use of diet drug fen-phen (fenfluramine-phentermine) cause valvular heart disease? HINT: Valvular heart disease is most objectively identified by echocardiography. A fairly high percentage of persons with valvular heart disease don’t have a detectable heart murmur and thus, would not be identified by physical examination alone. For this study, valvular heart disease will include mitral and aortic regurgitation. These are graded as absent, trace, mild, moderate, and severe. The Food and Drug Administration (FDA) criterion for significant...

  • 10 questions For the Disease Summary for this case study, see the CD-ROM PATIENT CASE HPI...

    10 questions For the Disease Summary for this case study, see the CD-ROM PATIENT CASE HPI Mr. H.Y. is a 63-year-old male, who presents to the ER with a two-day history of high-grade fever with chills. "I don't feel well and I think that I may have the flu," he tells the ER nurse and physician. He also complains of "some painful bumps on my fingers and toes that came on last night." He denies IVDA. When asked about recent...

  • Help 5-16 please For the Disease Summary for this case study, see the CD-ROM PATIENT CASE...

    Help 5-16 please For the Disease Summary for this case study, see the CD-ROM PATIENT CASE LHPI Mr. H.Y. is a 63-year-old male, who presents to the ER with a two-day history of high-grade fever with chills. "I don't feel well and I think that I may have the flu," he tells the ER nurse and physician. He also complains of "some painful bumps on my fingers and toes that came on last night." He denies IVDA. When asked about...

ADVERTISEMENT
Free Homework Help App
Download From Google Play
Scan Your Homework
to Get Instant Free Answers
Need Online Homework Help?
Ask a Question
Get Answers For Free
Most questions answered within 3 hours.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT